Latest
Dollar General promotes 18 executives
Dollar General has promoted 18 executives to new roles at the company. Leslie Allen has been promoted to senior vice president, human resources.
Upsher-Smith launches methimazole tablets
MAPLE GROVE, Minn. – Upsher-Smith Laboratories announced the recent launch of methimazole tablets, USP, 5 mg and 10 mg. The methimazole tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA.
Tylenol unveiling easy to swallow pain relief pill
Tylenol has launched Tylenol Easy to Swallow, a new pain relief pill designed specifically for people who dislike taking pills or have trouble swallowing — addressing an unmet need of 20% of consumers.
Award-winning director Grace Wethor to address 2024 NACDS Annual Meeting
ARLINGTON, Va. – Grace Wethor – an award-winning director, best-selling author, and brain cancer survivor and advocate – is set to speak at the 2024 National Association of Chain Drug Stores (NACDS) Annual Meeting in Palm Beach, FL. Wethor will present during the NACDS Luncheon on Monday, April 29.
WBA beats estimates for Q2 sales and profits
Walgreens Boots Alliance Inc. topped analysts’ forecasts for second quarter revenue and adjusted earnings. WBA posted adjusted earnings per share of $1.20, well above Wall Street’s predicted 82 cents. Sales of $37.05 billion exceeded the estimated $36.22 billion. The company posted a net loss of $5.
U.S. News reveals the 2024 Best OTC Medicine & Health Products
WASHINGTON – U.S. News & World Report, the global authority in health care rankings and consumer advice, today published the second annual Best OTC Medicine & Health Products.
LexisNexis Risk Solutions releases new fraud study
LexisNexis Risk Solutions has revealed the findings of the fourteenth edition of its annual LexisNexis True Cost of Fraud Study: Ecommerce and Retail Report – U.S. and Canada Edition. The report, based on a commissioned survey conducted by Forrester Consulting, shows that merchants in the U.S.
Rite Aid nears creditor deal to avoid liquidation
Rite Aid Corp. is nearing a deal with key bondholders and other creditor groups that will allow the pharmacy chain to avoid a liquidation, according to published reports.
Bridges Consumer Healthcare names Speranza new CEO
Bridges Consumer Healthcare, a consumer health care company focused on over-the-counter and personal care products, today announced the appointment of John Speranza as CEO. Speranza succeeds Robert Long, who has led the company since its formation in 2020.
CVS invests over $3M in organizations improving health outcomes in Phoenix
CVS Health announced more than $3 million in new grants to support organizations in Phoenix working to increase equitable access to health care, address social determinants of health and educate the community on the effects of air pollution.
Rolaids teams with Lil’ Drug Store Products
Lil’ Drug Store Products (LDSP) announces a strategic partnership with Procter & Gamble (P&G) for the preferred distribution of Rolaids – the trusted heartburn relief brand – to convenience and travel retailers nationwide.
Dr. Reddy’s inks exclusive distribution deal for Sanofi vaccines in India
Dr. Reddy’s Laboratories Ltd. has entered into an exclusive partnership with Sanofi Healthcare India Private Ltd. to promote and distribute the latter’s vaccine brands across private markets in India. Under the arrangement, Dr.
Study shows U.S. retailers’ shift towards customer-centric retail media networks
NEW YORK – Getting closer to their own customers was key for 41% of retailers when evolving their Retail Media Network (RMN) capabilities, the latest research from ADvendio, the leading omnichannel advertising solution provider, has shown. Original research of over 50 senior U.S.
Supreme Court could reject abortion pill challenge
A majority of Supreme Court justices appeared skeptical Tuesday of the idea of a nationwide ban or new limits on mifepristone, the primary drug used for medication abortions. The case was the first abortion-related hearing since the court reversed Roe v.
Cardinal Health annual research report examines milestone year in biosimilars
Cardinal Health has released its 2024 Biosimilars Report: insights on a pivotal year of evolution and expansion, an analysis of key recent economic, competitive, legislative and societal developments in biosimilars.